MetaTech AP Cash Flow Conversion Efficiency
MetaTech AP cash flow conversion efficiency. Based on the latest financial reports, MetaTech AP (3224) has a cash flow conversion efficiency ratio of -0.013x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-34.38 Million ≈ $-1.08 Million USD) by net assets (NT$2.66 Billion ≈ $83.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MetaTech AP (2017–2025)
Cash flow conversion efficiency of MetaTech AP from 2017 to 2025. This chart illustrates how MetaTech AP's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 3224 live share price for real-time trading data and today's change.
MetaTech AP Cash Flow Conversion Ratio Explained
MetaTech AP cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MetaTech AP Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MetaTech AP ranked by their cash flow conversion efficiency. Also see 3224 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elixir Energy Ltd
AU:EXR
|
-0.036x |
|
VivoPower PLC
NASDAQ:VIVO
|
N/A |
|
Kumkang Kind
KO:014280
|
-0.033x |
|
Wrap Technologies Inc
NASDAQ:WRAP
|
-0.182x |
|
Bullpen Parlay Acquisition Co
NASDAQ:BPAC
|
-0.005x |
|
Minaurum Silver Inc.
V:MGG
|
-0.431x |
|
Tacheng Real Estate Co Ltd
TWO:6171
|
-0.098x |
|
Gan Shmuel
TA:GSFI
|
0.035x |
Annual Cash Flow Conversion Efficiency for MetaTech AP (2017–2025)
The table below shows the annual cash flow conversion efficiency of MetaTech AP from 2017 to 2025. Review 3224 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.35 Billion ≈ $73.90 Million |
NT$-204.84 Million ≈ $-6.45 Million |
-0.087x | -26.15% |
| 2024-12-31 | NT$2.61 Billion ≈ $82.14 Million |
NT$-180.50 Million ≈ $-5.69 Million |
-0.069x | -290.34% |
| 2023-12-31 | NT$2.73 Billion ≈ $86.13 Million |
NT$99.43 Million ≈ $3.13 Million |
0.036x | +6283.19% |
| 2022-12-31 | NT$2.94 Billion ≈ $92.67 Million |
NT$1.68 Million ≈ $52.80K |
0.001x | +100.80% |
| 2021-12-31 | NT$2.96 Billion ≈ $93.19 Million |
NT$-211.78 Million ≈ $-6.67 Million |
-0.072x | -205.75% |
| 2020-12-31 | NT$915.07 Million ≈ $28.83 Million |
NT$-21.43 Million ≈ $-675.10K |
-0.023x | +60.89% |
| 2019-12-31 | NT$1.00 Billion ≈ $31.64 Million |
NT$-60.13 Million ≈ $-1.89 Million |
-0.060x | -1174.53% |
| 2018-12-31 | NT$1.07 Billion ≈ $33.80 Million |
NT$5.98 Million ≈ $188.34K |
0.006x | +104.86% |
| 2017-12-31 | NT$599.51 Million ≈ $18.89 Million |
NT$-68.79 Million ≈ $-2.17 Million |
-0.115x | -- |
About MetaTech AP
MetaTech (AP) Inc., together with its subsidiaries, engages in the wholesale and retail of electronic products and equipment in Hongkong, Taiwan, Singapore, and China. The company engages in the cell sheet development and medical production; cell therapy; and travel business. It also develops and operates biomedicine-related business. The company was incorporated in 1998 and is headquartered in N… Read more